These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 22314562)

  • 1. Cardioprotective role of sphingosine-1-phosphate.
    Knapp M
    J Physiol Pharmacol; 2011 Dec; 62(6):601-7. PubMed ID: 22314562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting sphingosine-1-phosphate signalling for cardioprotection.
    Kennedy S; Kane KA; Pyne NJ; Pyne S
    Curr Opin Pharmacol; 2009 Apr; 9(2):194-201. PubMed ID: 19070545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine-1-phosphate signaling in the cardiovascular system.
    Peters SL; Alewijnse AE
    Curr Opin Pharmacol; 2007 Apr; 7(2):186-92. PubMed ID: 17280869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.
    Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B
    Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate.
    Frias MA; James RW; Gerber-Wicht C; Lang U
    Cardiovasc Res; 2009 May; 82(2):313-23. PubMed ID: 19151362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43.
    Morel S; Christoffersen C; Axelsen LN; Montecucco F; Rochemont V; Frias MA; Mach F; James RW; Naus CC; Chanson M; Lampe PD; Nielsen MS; Nielsen LB; Kwak BR
    Cardiovasc Res; 2016 Mar; 109(3):385-96. PubMed ID: 26762268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine kinase and sphingosine 1-phosphate in cardioprotection.
    Karliner JS
    J Cardiovasc Pharmacol; 2009 Mar; 53(3):189-97. PubMed ID: 19247197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of cardioprotection by lysophospholipids.
    Karliner JS
    J Cell Biochem; 2004 Aug; 92(6):1095-103. PubMed ID: 15258895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine kinase and sphingosine 1-phosphate in asthma.
    Lai WQ; Wong WS; Leung BP
    Biosci Rep; 2011 Apr; 31(2):145-50. PubMed ID: 21091442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine can pre- and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate.
    Vessey DA; Li L; Kelley M; Zhang J; Karliner JS
    J Biochem Mol Toxicol; 2008; 22(2):113-8. PubMed ID: 18418901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma sphingosine-1-phosphate concentration is reduced in patients with myocardial infarction.
    Knapp M; Baranowski M; Czarnowski D; Lisowska A; Zabielski P; Górski J; Musiał W
    Med Sci Monit; 2009 Sep; 15(9):CR490-3. PubMed ID: 19721401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
    Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
    Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury.
    Means CK; Xiao CY; Li Z; Zhang T; Omens JH; Ishii I; Chun J; Brown JH
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2944-51. PubMed ID: 17293497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets.
    Huwiler A; Pfeilschifter J
    Biochem Pharmacol; 2008 May; 75(10):1893-900. PubMed ID: 18321471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of sphingolipids in respiratory disease.
    Yang Y; Uhlig S
    Ther Adv Respir Dis; 2011 Oct; 5(5):325-44. PubMed ID: 21900155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.
    Tao R; Zhang J; Vessey DA; Honbo N; Karliner JS
    Cardiovasc Res; 2007 Apr; 74(1):56-63. PubMed ID: 17320845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells.
    Schnitzer SE; Weigert A; Zhou J; Brüne B
    Mol Cancer Res; 2009 Mar; 7(3):393-401. PubMed ID: 19240180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine 1-phosphate signalling in cancer.
    Pyne NJ; Tonelli F; Lim KG; Long JS; Edwards J; Pyne S
    Biochem Soc Trans; 2012 Feb; 40(1):94-100. PubMed ID: 22260672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors.
    Bassi R; Anelli V; Giussani P; Tettamanti G; Viani P; Riboni L
    Glia; 2006 Apr; 53(6):621-30. PubMed ID: 16470810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection.
    Somers SJ; Frias M; Lacerda L; Opie LH; Lecour S
    Cardiovasc Drugs Ther; 2012 Jun; 26(3):227-37. PubMed ID: 22392184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.